Microglial Cytokines Induce Invasiveness and Proliferation of Human Glioblastoma through Pyk2 and FAK Activation.
Rebeca E NuñezMiguel Mayol Del ValleKyle OrtizLuis AlmodovarLilia Y KucheryavykhPublished in: Cancers (2021)
Glioblastoma is the most aggressive brain tumor in adults. Multiple lines of evidence suggest that microglia create a microenvironment favoring glioma invasion and proliferation. Our previous studies and literature reports indicated the involvement of focal adhesion kinase (FAK) and proline-rich tyrosine kinase 2 (Pyk2) in glioma cell proliferation and invasion, stimulated by tumor-infiltrating microglia. However, the specific microglia-released factors that modulate Pyk2 and FAK signaling in glioma cells are unknown. In this study, 20 human glioblastoma specimens were evaluated with the use of RT-PCR and western blotting. A Pierson correlation test demonstrated a correlation (0.6-1.0) between the gene expression levels for platelet-derived growth factor β(PDGFβ), stromal-derived factor 1α (SDF-1α), IL-6, IL-8, and epidermal growth factor (EGF) in tumor-purified microglia and levels of p-Pyk2 (Y579/Y580) and p-FAK(Y925) in glioma cells. siRNA knockdown against Pyk2 or FAK in three primary glioblastoma cell lines, developed from the investigated specimens, in combination with the cytokine receptor inhibitors gefitinib (1 μM), DMPQ (200 nM), and burixafor (1 μM) identified EGF, PDGFβ, and SDF-1α as key extracellular factors in the Pyk2- and FAK-dependent activation of invadopodia formation and the migration of glioma cells. EGF and IL-6 were identified as regulators of the Pyk2- and FAK-dependent activation of cell viability and mitosis.
Keyphrases
- growth factor
- cell migration
- tyrosine kinase
- inflammatory response
- gene expression
- neuropathic pain
- endothelial cells
- epidermal growth factor receptor
- small cell lung cancer
- systematic review
- signaling pathway
- dna methylation
- induced pluripotent stem cells
- south africa
- lipopolysaccharide induced
- single cell
- photodynamic therapy
- staphylococcus aureus
- pseudomonas aeruginosa
- cell therapy
- spinal cord
- escherichia coli
- angiotensin ii
- protein kinase
- high speed
- adverse drug